Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
about
Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytesVogt-Koyanagi-Harada syndrome - current perspectives.A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients.Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography.Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center.Autoimmune and autoinflammatory mechanisms in uveitis.Establishment of HLA-DR4 transgenic mice for the identification of CD4+ T cell epitopes of tumor-associated antigensRelationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease.Indocyanine green angiography guided management of vogt-koyanagi-harada disease.Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanomaKIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet's disease.Proteomic surveillance of retinal autoantigens in endogenous uveitis: implication of esterase D and brain-type creatine kinase as novel autoantigens.Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanomaImmunotherapy of autoimmunity and cancer: the penalty for success.Association of TNFSF4 Polymorphisms with Vogt-Koyanagi-Harada and Behcet's Disease in Han Chinese.New concepts in the appraisal and management of birdshot retinochoroiditis, a global perspective.Autoimmune uveitis: clinical, pathogenetic, and therapeutic features.Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease.Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality.Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's diseaseA study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.TRAF5 and TRAF3IP2 gene polymorphisms are associated with Behçet's disease and Vogt-Koyanagi-Harada syndrome: a case-control study.A Rare Case of Unilateral Progressive Vision Loss and Pachymeningitis.Ultra-wide-field green (532 nm) and red (633 nm) reflectance imaging of the "sunset glow" fundus in chronic Vogt-Koyanagi-Harada disease.Prevalence of uveitis in indigenous populations presenting to remote clinics of central Australia: the Central Australian Ocular Health Study.Guidelines for the diagnosis and treatment of vitiligo in Japan.Associations between TNFSF4, TNFSF8 and TNFSF15 and Behçet's disease but not VKH syndrome in Han Chinese.Evaluation of Vestibular Functions in Patients with Vogt-Koyanagi-Harada Disease.Vogt-Koyanagi-Harada Disease Associated with Influenza A Virus Infection: A Case Report.Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.Audiovestibular dysfunction associated with adoptive cell immunotherapy for melanoma.Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature.Audiovestibular findings in patients with Vogt-Koyanagi-Harada disease.Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment
P2860
Q26752297-E3B48A82-80E7-488B-A2CD-846BB534DF73Q28072882-A1623119-4C5F-4398-829D-272A902DAA2BQ33711379-7AA1BAB2-70E9-4081-9571-BC2D4CAB7368Q33823763-253B2C6A-7E5F-48F5-8B14-44B55C6A61E1Q33831207-5AFC65B0-9D36-4571-A1DD-4D7BADB391F0Q33939523-4B73E162-2CE7-41F2-9217-9D58C01FBF00Q34294964-6F484EA2-A42B-4D60-8F82-6B7347F2984FQ35081098-77E4754C-DBFB-4E0F-B310-FDAE375C8D32Q35548890-F979BD73-E79A-43A5-82FC-C27744C2BA33Q35835610-836A6443-DD3E-4153-9EEA-FBAE459E1607Q36041848-D5B53E3B-9460-49C7-91E0-BDF5019045EEQ36094774-AC392AC4-9FD5-45CB-8144-215F2511BA39Q36512305-D971B800-0D42-4E32-811E-8724CEC50A1AQ36717865-2A8A76E1-A0EF-4DD2-A598-6826A4A89A66Q37275309-747ED54A-0179-420A-A254-379915A10840Q37325451-AA35B030-708E-4A1C-8C13-C989BD603B2EQ37530629-9716F20D-2ADF-49D2-8FD0-AB4B739CC998Q38354864-351521A1-BE36-4625-A7DF-C9382BEB17D2Q38395263-A1C13780-781F-4938-88A8-46FBEBFA10C6Q38564159-2726C536-BD46-482E-913B-13D728B73501Q39008824-FAC6B960-B0E9-4563-8528-4F20EA9BC355Q39158352-8D4BD344-AA68-4ECA-B7D6-BDFE31DC3C7AQ40127737-23D924DF-8982-4997-88AD-F666C9F846D9Q41860239-C8307424-5D92-4FBD-9296-3BC5DB2D0004Q42363486-33EC91F7-8AFD-4A9C-B7CB-E6567F64867CQ42975458-1E9C4617-561B-481C-BE8F-CD499F6DD481Q45113836-3BB3815B-1DD8-4EEB-A753-58B3FE6B8278Q46146808-9A33DA81-3A38-4BDD-B366-DF8A89F90298Q47129890-26F9FE52-830D-4C2E-9C2B-231DAC97E6BCQ47231329-C96EE84C-D539-4CC9-9726-BD272431D182Q47555756-129FE618-9544-458D-BC1D-424EF7C73DECQ48369897-2916A50A-5AF8-4472-A05D-F72668EDAE91Q49266293-7D840EEB-164F-4296-86B0-2EF42FA4A960Q50098055-362162EE-2A9B-4457-B323-CD5F72EC74A0Q50425874-B4C2D4DE-0680-49CF-AC8C-CC3888DB26D9Q54453981-8F99E697-7E38-4749-8807-0B817D59DAF2Q57821296-CFF53FBF-B7AC-41CF-B0D8-A3EAA3E8C5E3
P2860
Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Ocular infiltrating CD4+ T cel ...... ize human melanocyte antigens.
@en
type
label
Ocular infiltrating CD4+ T cel ...... ize human melanocyte antigens.
@en
prefLabel
Ocular infiltrating CD4+ T cel ...... ize human melanocyte antigens.
@en
P2093
P356
P1476
Ocular infiltrating CD4+ T cel ...... ize human melanocyte antigens.
@en
P2093
Chikako Taguchi
Hiroshi Takase
Koju Kamoi
Kyogo Itoh
Manabu Mochizuki
Sunao Sugita
Tatsushi Kawaguchi
Yasuhisa Imai
Yoshiharu Sugamoto
Yuri Futagami
P304
P356
10.1167/IOVS.05-1547
P407
P577
2006-06-01T00:00:00Z